Grown Rogue International (GRUSF) Acquisitions (2009 - 2010)
Grown Rogue International (GRUSF) posted quarterly Acquisitions of $17539.7 for Q3 2010, down 20.54% year-over-year from $22074.4 in Q3 2009, and down 29.76% quarter-over-quarter from $24969.6 in Q2 2010.
Grown Rogue International (GRUSF) Acquisitions (2009 - 2010) Analysis & Trends
Grown Rogue International's Acquisitions history runs 2 years deep, the most recent figure standing at $17539.7 for Q3 2010.
- In Q3 2010, Acquisitions fell 20.54% year-over-year to $17539.7; the TTM figure through Oct 2021 stood at $83512.2 (changed N/A YoY), while the FY2021 annual figure was $76128.0, changed N/A from the prior year.
- Acquisitions for Q3 2010 stood at $17539.7, down from $24969.6 in the prior quarter.
- The five-year high for Acquisitions was $90787.4 in Q1 2009, with the low at $17539.7 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2010 | 17,539.69 |
| May 31, 2010 | 24,969.63 |
| Feb 28, 2010 | 41,002.84 |
| Aug 31, 2009 | 22,074.35 |
| May 31, 2009 | 39,504.42 |
| Feb 28, 2009 | 90,787.40 |